Skip to main content
TipRanks
Go Ultimate75% OFF

Medexus Pharmaceuticals Inc (P731) Stock Forecast & Price Target

2 Followers
See the Price Targets and Ratings of:

P731 Analyst Ratings

Currently, no data available

P731 Stock 12 Month Forecast

There Are No Analyst Ratings for P731 In The Last 3 Months.

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for DE:P731
Price TargetArticle
Bloom Burton€3.81→€4.13buy15.43%UpsideReiterated08/12/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
OVIDOvid Therapeutics
PTGXProtagonist Therapeutics
IMUXImmunic
IVAInventiva
PALIPalisade Bio

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Medexus Pharmaceuticals Inc

3 Months
David Martin PhD
David Martin PhDBloom Burton
Success Rate7/13 ratings generated profit
54%
Average Return
+9.28%

Copying David Martin PhD's trades and holding each position for 3 Months would result in 53.85% of your transactions generating a profit, with an average return of +9.28% per trade.

1 Year
David Martin PhD
David Martin PhDBloom Burton
Success Rate12/13 ratings generated profit
92%
Average Return
+47.46%

Copying David Martin PhD's trades and holding each position for 1 Year would result in 92.31% of your transactions generating a profit, with an average return of +47.46% per trade.

2 Years
David Martin PhD
David Martin PhDBloom Burton
Success Rate13/13 ratings generated profit
100%
Average Return
+85.79%

Copying David Martin PhD's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +85.79% per trade.

P731 Analyst Recommendation Trends

00.511.52Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26
Monthly rating counts for P731
RatingJul 26Aug 26Sep 26Oct 26Nov 26
Strong Buy00000
Buy12110
Hold00000
Sell00000
Strong Sell00000
total12110

In the current month, P731 has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. P731 average Analyst price target in the past 3 months is ―.

P731 Financial Forecast

€-2€-1.25€-0.5€0.25€1Q4 2026Q2 2027Q3 2027
High€0.09
Consensus€0.06
Low€0.05

P731 Earnings Forecast

Next quarter’s earnings estimate for P731 is EUR 0.06 with a range of EUR 0.05 to EUR 0.09. The previous quarter’s EPS was EUR 0.03. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

€21.5M€23.2M€24.9M€26.7M€28.4MQ4 2026Q2 2027Q3 2027
High€28.4M
Consensus€28M
Low€27.7M

P731 Sales Forecast

Next quarter’s sales forecast for P731 is EUR 28.02M with a range of EUR 27.75M to EUR 28.38M. The previous quarter’s sales results were EUR 25.89M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

P731 Stock Forecast FAQ

Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
What do analysts say about Medexus Pharmaceuticals Inc?
Not enough analysts have published a price target to provide an average price target.
How can I buy shares of Medexus Pharmaceuticals Inc?
To buy shares of DE:P731, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.